Is FBIO or RNXT more profitable?

FBIO runs the higher net margin — FBIO at 163.32% versus RNXT at -621.71%.

How have FBIO and RNXT total returns compared?

Over the past 5 years, FBIO delivered -46.06% and RNXT delivered -23.80% annualized total return. Past performance doesn't predict future results.

Fortress Biotech, Inc. (FBIO) vs RenovoRx, Inc. (RNXT)

A side-by-side comparison of Fortress Biotech, Inc. and RenovoRx, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FBIO

Fortress Biotech, Inc.

$68M

$2.05HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

RNXT

RenovoRx, Inc.

$64M

$1.43HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

Total return — FBIO vs RNXT

growth of $100 · dividends reinvested · last 5y

FBIO -95.7% (-46.7%/yr)RNXT -79.8% (-27.3%/yr)RNXT compounded faster over this window

FBIO RNXT

FBIO vs RNXT: by the numbers

•FBIO is the larger company ($68M vs $64M market cap).
•FBIO is profitable (163.32% net margin) while RNXT runs a net loss (-621.71%).

Metrics side by side

Valuation

Metric	FBIO	RNXT
P/E ratio	0.76	N/A
P/S ratio	0.99	32.60
P/B ratio	0.41	7.18
FCF yield	185.24%	N/A

Profitability

Metric	FBIO	RNXT
Gross margin	62.53%	70.88%
Operating margin	-111.00%	-1113.98%
Net margin	163.32%	-621.71%
ROE	68.12%	-136.82%
ROIC	-10.85%	-139.74%

Growth (annualized)

Metric	FBIO	RNXT
Revenue CAGR (5Y)	5.39%	N/A
Total return CAGR (5Y)	-46.06%	-23.80%

Frequently asked

Is FBIO or RNXT more profitable?: FBIO runs the higher net margin — FBIO at 163.32% versus RNXT at -621.71%.
How have FBIO and RNXT total returns compared?: Over the past 5 years, FBIO delivered -46.06% and RNXT delivered -23.80% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIO analysis Full RNXT analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Fortress Biotech ROE RenovoRx ROE Fortress Biotech operating margin RenovoRx operating margin Fortress Biotech revenue growth RenovoRx revenue growth Fortress Biotech free cash flow RenovoRx free cash flow

Fortress Biotech & RenovoRx appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.